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The E3 ubiquitin ligase NEDD4-2 (encoded by the Nedd4L gene) regulates the amiloride-sensitive epithelial Na+ 
channel (ENaC/SCNN1) to mediate Na+ homeostasis. Mutations in the human β/γENaC subunits that block 
NEDD4-2 binding or constitutive ablation of exons 6–8 of Nedd4L in mice both result in salt-sensitive hyper-
tension and elevated ENaC activity (Liddle syndrome). To determine the role of renal tubular NEDD4-2 in 
adult mice, we generated tetracycline-inducible, nephron-specific Nedd4L KO mice. Under standard and high-
Na+ diets, conditional KO mice displayed decreased plasma aldosterone but normal Na+/K+ balance. Under a 
high-Na+ diet, KO mice exhibited hypercalciuria and increased blood pressure, which were reversed by thiazide 
treatment. Protein expression of βENaC, γENaC, the renal outer medullary K+ channel (ROMK), and total and 
phosphorylated thiazide-sensitive Na+Cl– cotransporter (NCC) levels were increased in KO kidneys. Unex-
pectedly, Scnn1a mRNA, which encodes the αENaC subunit, was reduced and proteolytic cleavage of αENaC 
decreased. Taken together, these results demonstrate that loss of NEDD4-2 in adult renal tubules causes a new 
form of mild, salt-sensitive hypertension without hyperkalemia that is characterized by upregulation of NCC, 
elevation of β/γENaC, but not αENaC, and a normal Na+/K+ balance maintained by downregulation of ENaC 
activity and upregulation of ROMK.
Introduction
Hypertension is a major risk factor for stroke, myocardial infarc-
tion, and heart and kidney failure. The postmacula densa seg-
ments of the nephron, namely the distal convoluted tubule 
(DCT), the connecting tube (CNT) and the collecting duct (CD), 
control Na+ and K+ balance and thus extracellular volume and 
blood pressure. Na+ reabsorption occurs in the DCT by electro-
neutral cotransport via the thiazide-sensitive Na+Cl– cotrans-
porter (NCC) and in the late portion of the DCT (DCT2), CNT, 
and CD by electrogenic Na+ reabsorption through the amiloride-
sensitive epithelial Na+ channel (ENaC) (1). ENaC provides the 
driving force for K+ secretion via the renal outer medullary K+ 
channel (ROMK) (2).
The significance of these 3 renal segments for controlling 
Na+ balance and blood pressure is underscored by genetic dis-
eases affecting ENaC and NCC. Gain-of-function mutations 
within SCNN1 cause Liddle syndrome, which is characterized 
by increased ENaC activity, and result in salt retention and 
hypertension (3). Such mutations in β- and γENaC lead to inac-
tivation of the PY motif that interacts with WW domains of 
the ubiquitin-protein ligase NEDD4-2 (encoded by the Nedd4L 
gene), which ubiquitylates and degrades the channel (4–8). 
With increased aldosterone secretion, serum- and glucocorti-
coid-regulated kinase 1 (SGK1) interferes with ENaC ubiquity-
lation by NEDD4-2 (9). In addition, ENaC has been shown to 
be activated by proteolytic cleavage of the α and γ subunits that 
reflects ENaC activation and leads to channel with a higher 
open probability (10–12). Moreover, the α subunit is needed to 
bring β- and γENaC to the apical membrane, making functional 
channels (13–15).
The activity of NCC plays a major role in Na+ balance and 
blood pressure regulation. Thiazide diuretics, which inhibit 
NCC and lower blood pressure, and genetic mutations that sup-
press or heighten NCC function cause hypotension or hyper-
tension, respectively (16). NCC is also a downstream molecu-
lar target of the with-no-lysine WNK1/WNK4 kinases (17, 
18), the kelch-like KLHL3/Cullin 3 (CUL3) ubiquitin-protein 
ligase complex (19, 20), and the SGK1 kinase (21). Mutations 
in human proteins lead to overactive NCC and cause pseudo-
hypoaldosteronism type II (PHAII) (19, 20, 22), characterized 
by hyperkalemia, hypertension, hypercalciuria, and metabolic 
acidosis that can be treated by thiazides (23). Very recently, we 
have shown both in vitro and in vivo that Nedd4-2 is involved in 
NCC regulation (24).
Generation of constitutive Nedd4L KO mice, by removing exons 
6 to 8 of the Nedd4L gene (Nedd4L-Δ6-8 KO mice), demonstrated 
the importance of NEDD4-2 in the control of ENaC activity 
and blood pressure (25). Indeed, these mice displayed impaired 
Na+ excretion and hypertension, apparently mediated by ENaC 
overactivity (25). No effect on NCC was observed. To deter-
mine the role of renal NEDD4-2 in controlling Na+ balance and 
blood pressure during adulthood and to dissect the mechanisms 
behind this regulation, we developed inducible renal tubule–spe-
cific Nedd4Lflox/flox/Pax8-rTA/LC1 KO mice (Nedd4LPax8/LC1). Here, 
we show that loss of Nedd4L in adult renal tubules leads to some 
Authorship note: Johannes Loffing and Olivier Staub contributed equally to this 
work. John B. Stokes is deceased.
Conflict of interest: The authors have declared that no conflict of interest exists.
Citation for this article: J Clin Invest. doi:10.1172/JCI61110.
research article
2 The Journal of Clinical Investigation   http://www.jci.org
features of salt-sensitive PHAII with overactive NCC, leading 
to increased blood pressure and hypercalciuria. Interestingly, 
compensation by increased ROMK abundance and downregu-
lation of ENaC activity allows the maintenance of a normal 
Na+/K+ balance.
Results
Generation of inducible renal tubule–specific Nedd4L KO mice. Germ-
line deletion of exons 6 to 8 of the Nedd4L gene in mice leads to 
ENaC overactivation and hypertension (25). To determine the 
role of renal NEDD4-2 in regulating Na+ balance and blood pres-
sure in adult mice, we generated inducible renal tubule–specific 
Nedd4L KO mice using the same floxed allele used previously (25) 
and a combination of the inducible Tet-On and Cre-loxP systems, 
as previously described (24). Double-transgenic Nedd4Lflox/flox/
Pax8-rTA/LC1 (Nedd4LPax8/LC1) conditional KO mice and single-
transgenic Nedd4Lflox/flox/Pax8-rTA (Nedd4LPax8) or Nedd4Lflox/flox/
LC1 (Nedd4LLC1) control littermates were treated with doxycy-
cline as described previously (24). Immunofluorescence analysis 
showed that Cre recombinase is expressed in every tubular cell 
along the renal tubules of doxycycline-treated KO, but not in the 
blood vessels (Figure 1A). Consistent with previous report (26), 
Nedd4L mRNA could be detected in the proximal tubule (PT), 
DCT, CNT, and CD in microdissected tubules of control mice, 
but not in KO (Figure 1B). Western blot on total kidney lysates 
revealed a decrease of the 130-kDa NEDD4-2 protein in doxycy-
cline-treated KO mice (Figure 1C). Using several antibodies against 
NEDD4-2, we observed that the remaining band at 130 kDa was 
consistently present at low levels in the KO mice (Supplemental 
Figure 1; supplemental material available online with this article; 
doi:10.1172/JCI61110DS1). However, this band was complete-
ly lost when Western blots were performed on microdissected 
tubules (Figure 1D). These data indicate that the lower expression 
of NEDD4-2 observed on whole kidney extracts of KO mice cor-
responds to NEDD4-2 expressed in nontubular cells that were not 
targeted using the Pax8-rTA/LC1 system. Moreover, no additional 
truncated NEDD4-2 protein could be detected with the existing 
NEDD4-2 antibodies in the KO. As it was previously reported that 
the Pax8-rTA/LC1-mediated recombination system was leaky in 
some hepatocytes (27), we performed PCR to check the presence of 
recombination in liver and observed a weak band corresponding to 
the Nedd4L null allele in the KO (Supplemental Figure 2A). Howev-
er, immunoblotting on whole KO liver showed normal NEDD4-2 
protein expression in the KO (Supplemental Figure 2B). NEDD4-1 
protein, closely related to NEDD4-2 (28), was not upregulated in 
the Nedd4LPax8/LC1 KO mice, indicating that there is no compensa-
tion by this paralogue (Supplemental Figure 3).
Nedd4LPax8/LC1 KO mice show normal urine and plasma Na+ and K+ lev-
els. Control and KO mice were fed with a standard or high-Na+ diet 
and placed in metabolic cages to analyze Na+/K+ balance. Plasma 
aldosterone levels were strongly decreased in the KO mice under 
both diets, suggesting increased Na+ retention (Figure 2A). How-
ever, KO did not show any change in plasma Na+ and K+ concentra-
tions (Table 1). Moreover, after a change from standard to high-
Na+ diet, KO mice showed a tendency to retain Na+ compared with 
controls, but this was not statistically significant (Supplemental 
Figure 4). These data indicate either that the Nedd4LPax8/LC1 KO 
mice are able to maintain a normal Na+/K+ balance or that they 
have a modest Na+ retention that could not be detected by measur-
ing urinary Na+ excretion. Interestingly, when fed with a high-Na+ 
Figure 1
Generation of inducible renal tubule–specific Nedd4L KO mice. Nedd4Lflox/flox/Pax8-rTA/LC1 KO mice and control littermates (Nedd4LPax8 or 
Nedd4LLC1) were obtained and treated with doxycycline as described previously (24) to induce Nedd4L ablation in renal tubular cells. (A) 
Immunofluorescence for CRE and calbindin CaBP28 on kidney sections from control (left panel) and induced Nedd4LPax8/LC1 KO (right panel). 
CRE recombinase is expressed in all renal tubules in induced KO mice, including CaBP28-positive DCT/CNT cells (CRE: red; CaBP28: green; 
DAPI: blue). Scale bars: ∼50 μm. C, CNT; D, DCT. (B) Quantitative real-time PCR analysis for Nedd4L, Slc12a3 (encoding NCC), and aquapo-
rin 2 (Aqp2) mRNA on microdissected renal tubules normalized to Gapdh: Nedd4L mRNA is not detected in Nedd4LPax8/LC1 KO, and Slc12a3 
mRNA levels are unchanged (n = 4 per group, 8 days of high-Na+ diet). Slc12a3 was used as DCT marker and Aqp2 as CNT/CD marker. (C and 
D) Analysis of NEDD4-2 protein expression by Western blot in whole kidney lysates (C) and microdissected tubules (D). The lower NEDD4-2 
expression observed in KO whole-kidney lysates is absent in microdissected tubules (n = 3 mice per genotype). Load: unspecific band used as 
loading control. C, CNT/CD; P, PT; T, TAL.
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diet, KO mice displayed increased water consumption, elevated 
urine output, and diluted urine (Table 1), as previously observed 
in constitutive Nedd4L-Δ6-8 KO mice (25).
Loss of renal tubule NEDD4-2 in adult mice leads to salt-sensitive blood 
pressure increase. Systolic and diastolic arterial blood pressures (SBP 
and DBP) were measured by telemetry for 3 consecutive 24-hour 
periods upon standard and high-Na+ diets. No significant dif-
ference between Nedd4LPax8/LC1 KO and control littermates was 
observed under standard diet (Figure 2B). However, following 12 
days of high-Na+ diet, the difference between controls and KO 
reached 10 mmHg for the SBP during the active night period (Fig-
ure 2, B and C). These data indicate that renal tubule NEDD4-2 in 
adult mice is important for maintaining normal blood pressure 
under high-salt intake.
Nedd4L inactivation in adult renal tubules leads to increased β- and 
γENaC protein expression, but reduced αENaC proteolysis. Because 
NEDD4-2 has been shown to participate in the degradation of 
ENaC, it was expected that Nedd4L inactivation would result 
in more ENaC expression. Immunofluorescence showed that 
both β- and γENaC are strongly increased in Nedd4LPax8/LC1 
KO renal tubules (Figure 3, B and C, and Supplemental Fig-
ure 5). However, the cellular localization of both subunits was 
mainly cytoplasmic. Interestingly, αENaC expression was not 
increased in KO mice and seen predominantly at intracellular 
sites (Figure 3A and Supplemental Figure 5). Consistently, 
Scnn1a mRNA levels were lower in microdissected tubules of 
KO mice that paralleled the decreased plasma aldosterone levels 
observed in these mice (Figure 3D). On the other hand, Scnn1b 
and Scnn1g mRNA expression was unchanged (Figure 3, E and 
F). It is known that proteolytic cleavage of the α and γ sub-
units is involved in ENaC activation (10, 12, 29). We therefore 
analyzed by immunoblotting whether loss of NEDD4-2 would 
affect ENaC cleavage. Nedd4LPax8/LC1 KO mice showed a strong 
increase in the 90-kDa band for βENaC (Figure 3H). The same 
was observed for γENaC, but no 70-kDa cleaved form could 
be detected (Figure 3H). For αENaC, there was no change in 
the expression of the 90-kDa uncleaved band (quantification 
of blots from 3 independent experiments: controls: 1.00 ± 
0.22, n = 16; KO: 0.94 ± 0.18, n = 17; P = 0.818), but the 30-kDa 
cleaved band was decreased in the KO (controls: 1.00 ± 0.20, 
n = 16; KO: 0.48 ± 0.13, n = 17; P = 0.044) (Figure 3G). When 
aldosterone was administered to the Nedd4LPax8/LC1 KO mice 
using osmotic minipumps, both uncleaved and cleaved forms 
of αENaC expression increased and achieved comparable levels 
to those in the controls (Figure 3I). These results indicate that 
the downregulation of the αENaC proteolytic cleavage is due 
to decreased aldosterone. Taken together, our data suggest that 
ENaC activity is downregulated in Nedd4LPax8/LC1 KO mice.
Loss of renal tubule NEDD4-2 in adult mice leads to overactive NCC. 
We have recently showed that NEDD4-2 is involved in the regula-
tion of NCC at the posttranslational level (24). Here, we confirm, 
by using immunofluorescence, that loss of NEDD4-2 leads to 
increased NCC protein abundance (Figure 4A) without any change 
of Slc12a3 mRNA expression in microdissected renal tubules (Fig-
ure 1B). NCC immunostaining was hardly visible in control mice 
fed a high-Na+ diet, while an immunofluorescent signal was easily 
detectable in the KO mice. Immunoblotting data indicated that 
the elevated NCC phosphorylation at T53, T58, and S71, known 
to be involved in the activation of the cotransporter, followed the 
increased NCC protein abundance in KO (ref. 30 and Figure 4, B 
and C). To confirm our observation, we looked at NCC expression 
in kidneys from P19 Nedd4L-Δ15-16 KO mice generated by Boase 
et al. (31) and observed an increase of expression and phosphory-
lation of the cotransporter also in these mice (Supplemental Fig-
ure 6). Thus, we confirm that loss of NEDD4-2 leads to increased 
NCC. PHAII patients and mouse models with overactive NCC dis-
Figure 2
Inducible Nedd4LPax8/LC1 KO mice show decreased plasma aldoste-
rone and salt-sensitive blood pressure increase. (A) Plasma aldoste-
rone levels were decreased in induced Nedd4LPax8/LC1 KO (n = 7–10) 
compared with controls (n = 6–9) under both standard and high-Na+ 
diets. (B) Graphs represent SBP and DBP 12-hour night averages 
measured by telemetry in controls (n = 8) and Nedd4LPax8/LC1 KO 
(n = 6) under standard diet and after 3 and 12 days of high-Na+ diet. 
(C) SBP and DBP 24-hour profiles (day, white zone; night, gray zone) 
in controls (gray curve) and Nedd4LPax8/LC1 KO (black curve) after 12 
days of high-Na+ diet. ZT, Zeitgeber time (ZT0 or ZT24, light on; ZT12, 
light off). *P < 0.05, †P < 0.01, ‡P < 0.005, KO versus controls.
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play hypercalciuria that can be treated by thiazides, whereas hypo-
calciuria is observed in Slc12a3 KO mice (32). NCC activity is thus 
correlated with renal Ca2+ excretion. Based on this observation, we 
measured the urinary Ca2+ and found that the Nedd4LPax8/LC1 KO 
excrete more Ca2+ under a high-Na+ diet. Interestingly, thiazide 
treatment markedly reduced the elevated Ca2+ excretion in the KO, 
similar to what occurs in PHAII patients (Figure 4D). In addition, 
thiazide, but not amiloride, decreased the difference in blood pres-
sure between controls and KO during the active night period (Fig-
ure 4E). Taken together, these data suggest that loss of NEDD4-2 
in renal tubules in adult mice leads to increased NCC activity.
Nedd4LPax8/LC1 KO mice have increased ROMK abundance. Increased 
NCC activity has been shown to be linked with K+ retention (33, 
34). Therefore, the absence of hyperkalemia in Nedd4LPax8/LC1 KO 
mice was unexpected, as they do also show decreased ENaC activ-
ity and plasma aldosterone that should decrease the electrochemi-
cal driving force for K+ excretion via apical K+ channels such as 
ROMK in the ENaC-expressing cells. We therefore analyzed the 
abundance and subcellular localization of ROMK in control and 
KO mice. Interestingly, immunofluorescence showed a strong 
increase in ROMK protein abundance and apical localization in 
the DCT and CNT of Nedd4LPax8/LC1 KO (Figure 5A) and in CD and 
thick ascending limb (TAL) (Figure 5A). Kcnj1 mRNA expression 
levels (Figure 5B) were not different between controls and KO, 
indicating that loss of NEDD4-2 affects ROMK expression at the 
posttranslational level.
Nedd4L ablation in renal tubules during embryonic development results 
in a phenotype similar to that seen when the deletion occurs at adult age. 
Because the total Nedd4L-Δ6-8 KO mice showed no change in 
plasma aldosterone under standard and high-Na+ diets, increase 
in αENaC expression, and no alteration of NCC abundance (25), 
we hypothesized that the time of Nedd4L deletion may account 
for the differences with the Nedd4LPax8/LC1 KO mice. We treated the 
pregnant mothers of Nedd4LPax8/LC1 KO mice and control litter-
mates with doxycycline during gestation to induce deletion during 
embryonic development, as previously reported (27). We observed 
that the constitutive Nedd4L ablation in renal tubules had effects 
on NCC and α-, β- and γENaC expression (Figure 6, A–C) simi-
lar to those seen when the deletion was induced during adult-
hood. Moreover, the constitutive Nedd4LPax8/LC1 KO mice showed 
decreased plasma aldosterone (Figure 6D) and hypercalciuria 
(Table 2). These data suggest that the differences in phenotype 
between the Nedd4LPax8/LC1 KO mice and the total Nedd4L-Δ6-8 KO 
mice are most likely not due to early developmental adaptation, 
but rather to nonrenal NEDD4-2 or to the differences in genetic 
background between these mouse models.
Discussion
Mutations in human β- and γENaC leading to inactivation of the 
PY motif that interacts with NEDD4-2 WW domains cause Liddle 
syndrome, characterized by increased ENaC activity, salt reten-
tion, and hypertension (3). Surprisingly, constitutive deletion of 
exons 6 to 8 of the Nedd4L gene in the mouse results in amiloride-
sensitive salt-induced hypertension, but no sign of volume expan-
sion or impaired Na+/K+ balance (25). These observations raise the 
question on the role of renal NEDD4-2 in controlling ENaC and 
blood pressure. To address this issue, we generated inducible renal 
tubule–specific Nedd4L KO (Nedd4LPax8/LC1) mice. No Nedd4L mRNA 
corresponding to the deleted region as well as no protein product 
could be detected in microdissected renal tubules of Nedd4LPax8/LC1 
KO mice, suggesting that Nedd4L is efficiently deleted in the tar-
geted renal tubular cells. Recently, another constitutive Nedd4L KO 
mouse model was generated by constitutively deleting exons 15 and 
16 of the Nedd4L gene (Nedd4L-Δ15-16 KO mice) (31). Such deletion 
led to a perinatal lethal lung phenotype in contrast to the Nedd4L-
Δ6-8 KO model. Boase et al. provided evidence that production of a 
partial NEDD4-2 protein product in the lungs of the Nedd4L-Δ6-8 
KO may be the reason for the differences between the 2 models (31). 
Such truncated NEDD4-2 protein product was not detected in kid-
neys of our Nedd4LPax8/LC1 KO mice.
Table 1
Urine and plasma electrolytes in controls and inducible Nedd4LPax8/LC1 KO mice under standard and high-Na+ diet (8 days)
 Standard diet  High-Na+ diet 
 Controls Nedd4LPax8/LC1 Controls Nedd4LPax8/LC1
Food intake (g/g BW/24 h) 0.13 ± 0.00 (7) 0.15 ± 0.01 (4) 0.18 ± 0.01 (18) 0.17 ± 0.01 (15)
Water intake (ml/g BW/24 h) 0.31 ± 0.04 (7) 0.36 ± 0.03 (4) 0.32 ± 0.01 (21) 0.39 ± 0.02B (15)
Urine
Urine volume (ml/24 h) 0.13 ± 0.01 (7) 0.14 ± 0.02 (4) 0.13 ± 0.01 (21) 0.17 ± 0.01A (15)
Osmolality (mmol/g H2O) ND ND 2541 ± 204 (10) 1791 ± 72A (9)
Na+ excretion (μmol/24 h) 150 ± 15.8 (7) 187 ± 9.84 (4) 1375 ± 204 (10) 1352 ± 154 (14)
Na+/Cr (103) 0.03 ± 0.00 (7) 0.05 ± 0.01 (4) 0.59 ± 0.06 (7) 0.55 ± 0.08 (4)
K+ excretion (μmol/24 h) 520 ± 51.8 (7) 609 ± 71.7 (4) 428 ± 29.4 (21) 438 ± 30.2 (14)
K+/Cr (103) 0.10 ± 0.01 (7) 0.16 ± 0.02 (4) 0.14 ± 0.01 (7) 0.13 ± 0.02 (4)
Na+/K+ 0.27 ± 0.02 (7) 0.32 ± 0.03 (4) 3.07 ± 0.18 (18) 3.25 ± 0.35 (15)
GFR (ml/g BW/24 h) 14.3 ± 2.69 (7) 17.6 ± 3.30 (4) 12.9 ± 3.10 (8) 11.1 ± 0.87 (6)
pH 6.08 ± 0.04 (7) 6.17 ± 0.00 (4) 5.81 ± 0.20 (4) 5.91 ± 0.21 (6)
Plasma
Na+ (mM) 150 ± 1.26 (7) 147 ± 1.35 (4) 151 ± 1.14 (15) 151 ± 1.43 (11)
K+ (mM) 5.35 ± 0.29 (7) 6.19 ± 1.12 (4) 4.71 ± 0.19 (10) 4.72 ± 0.19 (10)
Blood pH ND ND 7.55 ± 0.04 (5) 7.58 ± 0.04 (7)
Values are given as average ± SEM. Number of mice indicated in parentheses. Cr, creatinine. AP < 0.05, BP < 0.005, KO versus controls.
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Surprisingly, despite the increase in NCC, and β- and γENaC 
protein levels and the decreased circulating aldosterone, sug-
gesting Na+ retention and confirming our previous report (24), 
Nedd4LPax8/LC1 KO mice showed normal urine and plasma Na+ and 
K+ levels. NCC has been reported to be activated by increasing its 
cell-surface expression and phosphorylation state, mainly via the 
WNK-SPAK/OSR1 pathway (17, 35). We found that NCC abun-
dance was increased in Nedd4LPax8/LC1 KO mice and is accompa-
nied by a proportional increase in phosphorylation of T53, T58, 
and S71 (30, 35). We also observed that Nedd4LPax8/LC1 KO mice 
have salt-sensitive blood pressure increase and hypercalciuria that 
could both be corrected by thiazides, corroborating the assump-
tion that the increased NCC is functional. Of interest, thiazides 
did not completely correct the high blood pressure, suggesting 
that mechanisms other than NCC activation are likely to contrib-
ute. Interestingly, β- and γENaC abundance were increased in the 
Nedd4LPax8/LC1 KO mice, but their cellular localization was mainly 
intracellular, and γENaC appeared to be in its uncleaved form. 
Unexpectedly, Scnn1a mRNA expression and proteolytic cleavage 
of the subunit were decreased in the Nedd4LPax8/LC1 KO mice, sug-
gesting ENaC downregulation. Moreover, amiloride treatment 
of Nedd4LPax8/LC1 KO mice did not decrease the high blood pres-
sure, indicating that ENaC is not involved in the hypertensive 
phenotype. Interestingly, the ENaC downregulation observed in 
the Nedd4LPax8/LC1 KO mice paralleled the decreased plasma aldo-
sterone and could be rescued by administrating aldosterone to 
the KO mice. These data confirm (a) the crucial role of aldoste-
rone in controlling αENaC expression in the kidney (36), and (b) 
the importance of αENaC for apical trafficking of the 2 other 
ENaC subunits (37). To our knowledge, this is the first in vivo 
study showing differential regulation between the upregulation 
of β/γENaC (a likely result of the lack of ubiquitylation) and 
the downregulation of proteolytic activation of αENaC due to 
decreased aldosterone. Interestingly, no human mutation in 
the gene encoding αENaC (Scnn1a) has been reported to cause 
Liddle syndrome. Taken together, these results give new insights 
about how the different mechanisms involved in ENaC regula-
tion can interact and compensate each other if one is impaired. 
However, our results stand in contrast with the phenotype of 
Liddle syndrome, where ENaC activity is increased despite the 
low circulating aldosterone levels (38). It is likely that deletion 
of Nedd4L affects other factors, such as NCC upregulation and 
consequent compensatory pathways, or other factors involved 
in controlling ENaC activity or trafficking (39). Because modi-
fications in the abundance of individual renal Na+ transporters 
often result in compensatory changes in the expression levels of 
other Na+ transporters to maintain Na+ balance (40), we propose 
that NEDD4-2 deficiency leads to increased NCC-mediated Na+ 
reabsorption, which is compensated by decreased ENaC activity. 
Consistent with our hypothesis, KO mice for the kidney-specific 
KS-Wnk1 isoform, in which NCC is strongly upregulated, pres-
ent a very similar phenotype with downregulation of the 3 ENaC 
subunits (41). Of interest, the phenotype of the Nedd4LPax8/LC1 KO 
mice is the mirror image of the Slc12a3 KO, which show increased 
plasma aldosterone, decreased calciuria, and upregulation of 
ENaC activity in CD (28).
Figure 3
Nedd4LPax8/LC1 KO mice have increased β- and 
γENaC abundance, but not αENaC. (A–C) 
Immunostaining for α- (A), β- (B), and γENaC (C) on 
kidney cryosections of control and KO mice under 
high-Na+ diet. Cytoplasmic β- and γENaC abun-
dance is increased in CD of KO, whereas αENaC is 
decreased. Scale bars: ∼20 μm. (D) TaqMan analysis 
of Scnn1a mRNA on microdissected renal tubules 
shows downregulation in KO (n = 4 per group). (E 
and F) TaqMan analysis for Scnn1b (E) and Scnn1g 
(F) mRNA on whole kidney (n = 6 per genotype). 
mRNA expression was normalized to Gapdh mRNA 
levels and expressed relative to control values. (G 
and H) Representative Western blots for α-, β-, 
and γENaC: the cleaved 30-kDa αENaC band was 
decreased in Nedd4LPax8/LC1 KO mice (G), whereas 
β- and γENaC expression were elevated (H). For 
γENaC, lanes were run on the same gel but were 
noncontiguous, as indicated by the vertical black 
line. (I) Aldosterone infusion in Nedd4LPax8/LC1 KO 
mice results in increased αENaC protein (uncleaved 
and cleaved form) expression, suggesting that the 
reduced expression observed in the KO is due to 
the decreased plasma aldosterone. Kidney extract 
from Scnn1a KO mice was used as negative control. 
Lanes that were run on the same gel but were non-
contiguous are indicated with the vertical black lines. 
*P < 0.05, KO versus controls. Ctrl, control mice.
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Our results in the Nedd4LPax8/LC1 KO mice are however different 
to what was observed in the total Nedd4L-Δ6-8 KO mice, in which 
NCC was unchanged and all 3 ENaC subunits were increased 
(25). One substantial difference between the 2 models is the 
plasma aldosterone that is much higher in the total Nedd4L-Δ6-8 
KO mice and could be attributed to the systemic effects. This dif-
ference in plasma aldosterone could explain many of the chang-
es, especially with regard to ENaC. Compensatory mechanisms 
that could occur during development in the total Nedd4L-Δ6-8 
KO mice may also explain the difference with our inducible sys-
tem. However, when we induced the renal Nedd4L deletion during 
embryonic development, we obtained a phenotype similar to that 
in the postnatal deletion of renal Nedd4L, with decreased plasma 
aldosterone, increased NCC, and decreased αENaC proteolysis. 
Therefore, the differences with the total Nedd4L-Δ6-8 KO model 
could rather be due to variations in genetic background or to 
loss of nontubular NEDD4-2 function. Indeed, Van Huysse et 
al. recently demonstrated that the salt-induced elevated blood 
pressure in the Nedd4L-Δ6-8 KO mouse model depends critically 
on ENaC overexpression in the brain (42).
Interestingly, despite the strong increase in renal NCC expres-
sion levels, the Nedd4LPax8/LC1 KO mice displayed some but not all 
the features characteristic of PHAII. The role of NCC overactiva-
tion in developing PHAII has been highlighted by human muta-
tions and animal models. Wilson et al. first identified mutations 
in the WNK1 and WNK4 genes in some patients with PHAII (22). 
The PHAII-Wnk4Q562E transgenic mouse model developed by Lali-
oti et al. exhibits increased NCC and PHAII features that could be 
abolished by crossing these mice with Slc12a3 KO mice (33). Yang 
et al. generated mice with 1 normal copy of Wnk4 and 1 mutant 
Wnk4D561A (34). These mice displayed increased phosphorylation 
and expression of NCC as well as hypertension and hyperkalemia 
that could be treated with thiazide. However, there is now increasing 
evidence that overactive NCC alone is not sufficient to lead to PHAII 
and that the deregulation of other channels or transporters might 
be required. As mentioned above, KS-Wnk1 KO mice, with strong 
increase in NCC and decreased ENaC, showed only few of the PHAII 
features (41). In addition, a recent study of NCC overexpression in 
mice showed no effect on blood pressure, plasma, or urine electro-
lyte and urinary Ca2+ (43). One of the PHAII features that is missing 
Figure 4
NCC is overactivated in Nedd4LPax8/LC1 
KO mice. (A) Immunofluorescence for 
NCC on kidney sections of control and KO 
mice under high-Na+ diet. NCC expression 
is increased in DCT of KO. Scale bars: 
∼20 μm. (B) Western blot analysis for total 
NCC and phosphorylated pT53-, pT58-, 
pS71-, and pT43/53/58-NCC. A represen-
tative blot on 5 controls and 5 KO is shown. 
For pS71-NCC and pT43/53/58-NCC, 
lanes that were run on the same gel but 
noncontiguous are indicated with a vertical 
black line. (C) Graphs show quantification 
of Western blots for phosphorylated NCC 
and the corresponding total NCC from 2 
independent experiments (pT53-NCC and 
pT58-NCC: n = 5 per genotype; pS71-NCC 
and p43/53/58-NCC: n = 11 per geno-
type). Protein expression was normalized 
to the amount of β-actin or β-tubulin and 
expressed relative to control values. (D) 
Urine Ca2+ measurement in control and 
KO mice under high-Na+ diet (10 days). 
Nedd4LPax8/LC1 KO are hypercalciuric 
as shown by the 3-fold increased urine 
Ca2+/creatinine (Cr) ratio, which can be 
corrected by thiazide (n = 4 per group). 
Vh, vehicle; Tz, thiazide. (E) Plot showing 
telemetric measurement on controls ver-
sus KO under high-Na+ diet. The increased 
SBP and DBP observed in KO after 5 
weeks of high-Na+ diet can be prevented 
by thiazide, but not by amiloride (n = 4 per 
group). *P < 0.05, **P < 0.01, KO versus 
controls. †P < 0.05, ††P < 0.01, thiazide 
versus vehicle.
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in the Nedd4LPax8/LC1 KO mice is the hyperkalemia. Several lines of 
evidence have shown that NCC is important for K+ conservation, as 
Gitelman patients (44) and Slc12a3 KO mice exhibit hypokalemia 
(45) and hyperkalemia is observed in PHAII patients (33, 34). The 
increased ROMK abundance observed in the Nedd4LPax8/LC1 KO mice, 
which could result from the lack of NEDD4-2–mediated ubiquity-
lation (46), may lead to higher K+ excretion, as it has been reported 
for the KS-Wnk1 KO mice (41). Another possibility could be that the 
Nedd4LPax8/LC1 KO mice have some residual ENaC activity sufficient 
for excreting enough K+ to maintain a normal kalemia. Whether 
some ENaC-independent K+ secretion occurs in the Nedd4LPax8/LC1 
KO mice remains to be addressed.
In conclusion, we provide evidence that inactivation of Nedd4L 
exons 6 to 8 in renal tubules of adult mice does not lead to a Lid-
dle syndrome phenotype associated with elevated ENaC activity, 
but rather causes a salt-sensitive PHAII-like syndrome with NCC 
upregulation, increased blood pressure, and hypercalciuria. Based 
on these results, NEDD4-2 appears to primarily target NCC and 
might thus be an attractive target to treat hypertension, avoid-
ing the most severe side effect of thiazides, namely hypokalemia. 
Moreover, there is an interesting clinical association of hypercal-
ciuria with hypertension and an increased risk of nephrolithiasis 
in hypertension (47–50). Defects in NEDD4-2 could therefore 
underlie these associations, and its study could lead to important 
mechanistic insights. The recent discoveries that mutations in 
KLHL3 and CUL3 (part of a ubiquitin-protein ligase complex) lead 
to PHAII demonstrate the importance of the ubiquitylation pro-
cess in the control of NCC activation. In addition, Khan et al. very 
recently demonstrated that NCC ubiquitylation is regulated by 
phosphorylation of the cotransporter and may contribute to the 
control of NCC surface expression (51). Finally, our data suggest 
that under high-Na+ intake, NEDD4-2 is not crucial for regulating 
renal ENaC, as the low plasma aldosterone leading to decreased 
αENaC proteolytic cleavage is probably sufficient to counterbal-
ance the increased β- and γENaC abundance in the Nedd4LPax8/LC1 
KO mice and thus to compensate for the increased NCC activity 
and maintain normal Na+/K+ balance. Why other pathways known 
to regulate NCC, such WNK-SPAK/OSR1, do not compensate for 
the increased NCC activity resulting from the lack of NEDD4-2 
represents an important question for further investigation.
Methods
Generation and induction of renal tubule–specific Nedd4L KO mice. Inducible 
renal tubule–specific Nedd4Lflox/flox/Pax8-rTA/LC1 KO (Nedd4LPax8/LC1) mice 
were generated as described previously (24). Genotyping and recombi-
nation of PCR were performed as described in Supplemental Methods. 
Three- to 4-week-old KO and single transgenic homozygous Nedd4LPax8 or 
Nedd4LLC1 littermates (controls) were treated with doxycycline (2 mg/ml 
in 2% sucrose in drinking water) for 11 days. All experiments were started 
1 day after the end of the induction, if not stated otherwise. To delete 
Nedd4L during embryonic development, pregnant females were treated 
with doxycycline as described above during the breeding and gestation 
periods, and resulting pups were treated until weaning. Induced mice were 
fed a standard (0.18% Na+; Sniff) or high-Na+ diet (>3.2% Na+) for 8 days 
and placed in metabolic cages to measure BW, water, and food consump-
tion and to collect urine for 24 hours. For thiazide treatment, mice were 
injected i.p. at Zeitgeber time ZT2 (2 hours after light on) with vehicle or 
thiazide (20 mg/kg BW) and urine was collected 6, 12, 24, and 30 hours 
after injection. Creatinine and Ca2+ were measured by the Laboratory of 
Clinical Chemistry at the Lausanne Hospital (CHUV) using a Modular 
Figure 5
Nedd4LPax8/LC1 KO mice have increased ROMK abundance. (A) 
Immunofluorescence for ROMK on kidney sections from control 
and KO mice fed with high-Na+ diet (10 days) shows increase in 
the channel in DCT2 (D2), CNT (CN), CD and TAL (T) in KO. Scale 
bars: ∼40 μm. (B) TaqMan analysis showed that Kcnj1 mRNA levels 
are not changed between controls and KO mice on whole kidney.
Figure 6
Nedd4L ablation in renal tubules during embryonic development 
results in phenotype similar to that seen when the deletion occurs 
at adult age. Mice were treated with doxycycline during embryonic 
development to induce Nedd4L ablation early on. (A–C) Western blot 
analysis on 5-week-old control and KO mice showed increased NCC 
(A), β-, and γENaC (C) expression, and decreased cleaved αENaC 
under high-Na+ diet (10 days) (B). (D) Plasma aldosterone levels were 
decreased in KO (n = 7) compared with control mice (n = 7) under 
standard diet. *P < 0.05, KO versus controls.
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Analytics System (Roche Diagnostics). Mice were anesthetized by isoflu-
rane inhalation for blood collection by retroorbital plexus puncture and 
sacrificed by cervical dislocation for tissue collection.
Inducible renal tubule–specific Scnn1a KO mice. Scnn1aflox/flox/Pax8-rTA/
LC1 KO mice were generated and induced as described above for the 
Nedd4LPax8/LC1 KO mice, but using Scnn1aflox/flox mice (52).
Microdissection of mouse renal tubules. Kidneys were perfused and microdis-
sected as described previously (53). For each tubular segment (PT, TAL, 
DCT, or CNT/CD), tubules microdissected from 3 mice were pooled 
together with equal tubular length (controls: 6–8 cm; KO: 12 cm to be sure 
not to miss any weak signal in comparison with controls).
Real-time quantitative PCR. Total RNA was isolated from kidney using the 
RNAquous Kit (Ambion) (1 μg) or from renal tubules microdissected as 
described in (53) using the RNeasy MicroKit (QIAGEN). RNA was reverse-
transcribed and used for real-time quantitative PCR as described (24). 
Information about TaqMan Gene Expression Assays (Applied Biosystems) 
and primer/probe sequences are given in Supplemental Table 1. Regarding 
Nedd4L, the probe and primers were chosen to be located in the exon 6 to 8 
region that was deleted in the KO mice after doxycycline treatment.
Measurement of urine and plasma metabolites and aldosterone. Urinary and 
plasma Na+ and K+ were measured using a flame photometer (Cole-Palm-
er Instrument), and urine osmolality with an Advanced 2020 osmometer 
(Advanced Instruments). Glomerular filtration rate (GFR) was estimated 
based on creatinine clearance. Plasma aldosterone levels were measured 
as described (24).
Telemetry. Experiments were performed on 1.5-month-old male con-
trols and induced KO as described (41). Mice were fed a standard diet for 
7 days, a low-Na+ diet (<0.01% Na+; Sniff) for 7 days, and then a high-Na+ 
diet for up to 5 weeks. After a 10-day recovery period, cardiovascular 
parameters were recorded 9 seconds every minute for 24 hours in a light/
dark-cycle (ZT0-ZT12/ZT12-ZT24). For thiazide and amiloride experi-
ments, mice were injected i.p. with either vehicle, thiazide (20 mg/kg 
BW), or amiloride (5 mg/kg BW) at ZT11 and blood pressure was mea-
sured during the active night period between 2 hours (ZT13) and 9 
hours (ZT20) after injection.
Aldosterone treatment. The ALZET 1003D osmotic 
mini-pumps (preloaded with vehicle or aldosterone 
to get a dose of 150 μg/kg BW/d for 3 days) were 
implanted s.c. Mice were kept on a low-Na+ diet, from 
the implantation day until sacrifice, to avoid aldoste-
rone escape.
Immunoblotting. Frozen tissues were homogenized 
and protein extracted as described (24). Anti–α-, –β-, 
and –γENaC were used as described (14). Kidneys 
from inducible renal tubule–specific Scnn1a KO mice 
were used as controls for the ENaC-specific bands. 
For analysis of protein expression in Nedd4L total 
KO mice, kidneys from P19 Nedd4L-Δ15-16 total 
KO mice (31) were used. NEDD4-2 was detected 
using an anti–NEDD4-2 generated in the labora-
tory of S. Kumar and diluted 1/1000 (31) or with 
other antibodies directed against different regions of 
NEDD4-2 and described in Supplemental Methods. 
NEDD4-1 was detected as described in Supplemental 
Methods. NCC was detected with an anti-NCC anti-
body (Chemicon). For anti-phosphorylated pT53-
NCC and pT58-NCC, peptide-synthesis, immuni-
zations of rabbits, and antibody purifications were 
custom-made by Pineda Antibody Services. Phospho-
antibodies were preincubated with the correspond-
ing non–phospho-peptides and diluted 1/5000. Anti-phosphorylated 
pS71-NCC and anti-pT43/53/58-NCC were provided by D. Alessi (MRC 
Protein Phosphorylation Unit, University of Dundee, Dundee, United 
Kingdom) and preincubated with the corresponding non–phospho-pep-
tide (35, 54). Anti–β-actin or anti–β-tubulin antibody (Sigma-Aldrich) 
was used as loading control. For protein analysis on microdissected 
renal tubules, Western blots were performed as described (53) using the 
NEDD4-2 antibody previously described (31).
Immunofluorescence. Kidneys were processed and cryosections incubat-
ed with antibodies against CRE, α-, β-, γENaC, NCC, and ROMK1,2 as 
described (15, 55).
Statistics. All values are presented as mean ± SEM. The data were analyzed 
using unpaired 2-tailed Student’s t test, KO versus controls. For thiazide 
and amiloride injection, a paired t test was used, diuretic injected versus 
vehicle injected. A P value of less than 0.05 was considered significant.
Study approval. All experimental procedures were approved by the Swiss 
Federal Veterinary Office and carried out in accordance with the local ani-
mal welfare act.
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Table 2
Urine and plasma electrolytes in controls and constitutive Nedd4LPax8/LC1 KO mice 
under high-Na+ diet (8 days)
 Controls Nedd4LPax8/LC1
Food intake (g/g BW/24 h) 0.20 ± 0.01 (9) 0.20 ± 0.01 (7)
Water intake (ml/g BW/24 h) 0.61 ± 0.06 (9) 0.67 ± 0.05 (6)
Urine
Urine volume (ml/g BW/24 h) 0.23 ± 0.03 (9) 0.30 ± 0.02A (7)
Ca2+ excretion (μmol/24 h) 13.5 ± 3.88 (9) 44.3 ± 7.16B (7)
Ca2+/Cr (103) 2.84 ± 0.52 (9) 7.50 ± 0.98B (9)
Na+ excretion (μmol/24 h) 2192 ± 232 (9) 2249 ± 279 (7)
Na+/Cr (103) 0.66 ± 0.04 (9) 0.61 ± 0.06 (7)
K+ excretion (μmol/24 h) 538 ± 40.0 (9) 639 ± 42.0 (7)
K+/Cr (103) 0.16 ± 0.01 (9) 0.17 ± 0.01 (7)
Na+/K+ 4.02 ± 0.20 (9) 3.49 ± 0.30 (7)
GFR (ml/g BW/24 h) 15.9 ± 1.38 (8) 15.6 ± 1.40 (5)
Plasma
Na+ (mM) 151 ± 0.47 (9) 152 ± 0.81 (7)
K+ (mM) 4.20 ± 0.16 (9) 4.16 ± 0.20 (7)
Values are given as average ± SEM. Number of mice indicated in parentheses. AP < 0.05,  
BP < 0.005, KO versus controls.
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